MFOCX
Price
$29.52
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
RGEBX
Price
$73.96
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

MFOCX vs RGEBX

Header iconMFOCX vs RGEBX Comparison
Open Charts MFOCX vs RGEBXBanner chart's image
Marsico Focus
Price$29.52
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.96
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MFOCX vs RGEBX Comparison Chart
Loading...
VS
MFOCX vs. RGEBX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFOCX is a StrongBuy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 284B vs. MFOCX (1.01B). RGEBX pays higher dividends than MFOCX: RGEBX (0.16) vs MFOCX (0.00). MFOCX was incepted earlier than RGEBX: MFOCX (27 years) vs RGEBX (10 years). MFOCX is a more actively managed with annual turnover of: 76.00 vs. RGEBX (31.00). RGEBX has a lower initial minimum investment than MFOCX: RGEBX (250) vs MFOCX (2500). MFOCX annual gain was more profitable for investors over the last year : 40.03 vs. RGEBX (22.86). MFOCX return over 5 years is better than : 52.65 vs. RGEBX (47.60).
MFOCXRGEBXMFOCX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years10 years-
Gain YTD30.03618.896159%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B284B0%
Annual Yield % from dividends0.000.16-
Returns for 1 year40.0322.86175%
Returns for 3 years-5.48-4.80114%
Returns for 5 years52.6547.60111%
Returns for 10 years26.9456.2548%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLNE158.621.25
+0.79%
Hamilton Lane
IE7.390.03
+0.41%
Ivanhoe Electric
HLN10.55-0.10
-0.94%
Haleon plc
COMM5.60-0.08
-1.41%
CommScope Holding Company
QNCX0.74-0.02
-2.65%
Quince Therapeutics